Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Regeneration Technologies, Inc.

This article was originally published in The Gray Sheet

Executive Summary

Alachua, Florida human allograft tissue implant processor amends lawsuit against Musculoskeletal Transplant Foundation (MTF) to add charges that MTF made false and misleading claims that its human allograft tissue is sterile. RTI originally filed suit against the non-profit tissue provider in the U.S. District Court for the Northern District of Florida in Gainesville alleging that an MTF advertising campaign disparaged RTI products as unsafe. The suit charges MTF with false advertising, unfair competition and intentional interference with RTI's business relationships (1"The Gray Sheet" June 18, 2001, In Brief)

Latest Headlines
See All
UsernamePublicRestriction

Register

MT015223

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel